Please login to the form below

Not currently logged in
Email:
Password:

Breo

This page shows the latest Breo news and features for those working in and with pharma, biotech and healthcare.

GSK gets maintenance indication for Trelegy

GSK gets maintenance indication for Trelegy

GSK claims Trelegy has made the strongest start of any of GSK’s new Ellipta range of respiratory meds, which also includes Relvar/Breo (fluticasone furoate/vilanterol) and Anoro (vilanterol/umeclidinium

Latest news

More from news
Approximately 11 fully matching, plus 34 partially matching documents found.

Latest Intelligence

  • Pharma deals during May 2013 Pharma deals during May 2013

    First in this was the purchase for $1bn of 21 per cent of the respiratory product royalties Theravance receives, including the royalties on the recently US approved Breo for COPD being

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics